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Summary.-CEA-like antigen has been detected on the surface of some melanoma
cells using a rabbit antiserum raised against CEA antigen in 51Cr-release leucocyte-
dependent cytotoxic-antibody (LDA) assays. The CEA antigen used for production
of the antiserum was shown to be immunologically pure by immunoelectrophoresis
procedures and reacted with a reference serum to CEA. The specificity of the CEA
antiserum for CEA on the melanoma cells was further shown by removal of reactivity
to melanoma cells after absorption on CEA affinity columns. LDA activity to CEA
was also shown in a serum taken during pregnancy. No CEA LDA activity was found
in several melanoma sera. These findings suggest that CEA may have biological
significance in tumour rejection, and that CEA assays may be of value in monitoring
disease activity in melanoma patients.
THE CARCINOEMIBRYONIC ANTIGEN (CEA)
as first described by Gold and Freedman
(1965) was believed to be a tumour-
associated antigen arising in tumours and
foetal tissue of entodermal origin. Further
studies have indicated that CEA or
CEA-like materials may be detected in,
in addition to tissues of entodermal
origin, a large variety of normal and
neoplastic tissues, such as lung, breast
(Moore et al., 1971; Laurence et al.,
1972) urogenital tract (Hall et al., 1972;
Neville et al., 1973) and erythrocyte
membranes (Nery, Bullman and Bar-
soum, 1973; Neville and Laurence, 1974).
It is also known that foetal-type anti-
gens can be detected on both long- and
short-term cultured melanoma cells (Mach-
er et al., 1975; Jerry et al., 1976; V7iza,
Phillips and Trejdosiewicz, 1975; Hersey
et al., 1976) and tend to occur in greater
density on long-term cultured cells (Her-
sey et al., 1976). In the present study the
possibility that the foetal antigens identi-
fied on melanoma cells were, in part,
CEA was examined in short- and long-
term cultures. Antisera to CEA were
tested against melanoma cells by leuco-
cyte-dependent cytotoxic-antibody assays
(LDA). Immunoabsorption techniques
were used to establish the specificity
of the reactions. The results appear to
indicate that CEA can be identified on
some melanoma cells by these assays,
and that this antigen may, therefore,
have biological significance in tumour
rejection.
MATERIALS AND METHODS
CEA antigen preparation
CEA was prepared from 288 g of the
hepatic metastases of a carcinoma of the
colon, as previously described (Extract IL,
Hughes, 1975). In brief, the tissue was
extracted with 0-6 M perchloric acid, the
extract neutralized with 1 N NaOH and
concentrated to a volume of 15 ml by ultra-
filtration through a UM-10 Diaflo filter
(Amicon Corp., Lexington, Mass.). CEA was
then obtained by sequentially chromato-
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graphing the extract on (1) Sephadex G-100
at pH 7-2, (2) DEAE Sephadex at pH 7-2
using an increasing NaCl concentration
gradient for elution, (3) Sepharose 6B at
pH 7-2, (4) DEAE Sephadex at pH 4-6
using an increasing NaCl concentration
gradient for elution and, finally, on Sepharose
6B at pH 4-5. At each fractionation step,
fractions containing CEA were pooled, con-
centrated by ultrafiltration and tested by
Ouchterlony double diffusion and immuno-
electrophoresis, using an unabsorbed anti-
serum to perchloric acid extracts of colonic
carcinoma and an antiserum recognizing
both CEA and the so-called Ca-2 antigen
which cross-reacts with CEA (Hughes, 1973).
Fractions were also tested by electrophoresis
in agarose and staining the patterns so
obtained with Coomassie blue, the periodic-
acid-Schiff reaction for carbohydrate and
toluidine blue stain for metachromasia.
The pure preparation of CEA was freeze-
dried, weighed and redissolved to give a
protein concentration of 1-042%.
Antisera
(i) Rabbit anti-CEA serum.-An antiserum
to CEA was produced in a rabbit by 4
injections over a 63-day period of a total
of 1016 ,ug of a pure preparation of CEA
isolated as previously described (Extract
4Ca, Hughes, 1975) from 546 g of colonic
carcinoma tissue obtained from 23 patients.
When tested by Ouchterlony double diffusion
against concentrated perchloric-acid extracts
of normal colon and colonic carcinoma, this
antiserum recognized two antigens, one of
which gave a reaction of complete immuno-
logical identity with the single antigen
recognized by an antiserum to CEA obtained
from Dr P. Gold, Montreal General Hospital.
The second antigen recognized by the anti-
serum was the so-called Ca-2 antigen which
has been shown to share at least one antigenic
determinant with CEA, although it does not
possess the antigenic determinant specific to
CEA (Hughes, 1973, 1975). To render the
antiserum specific for CEA, preparations of
the Ca-2 antigen obtained during the frac-
tionation ofperchloric-acid extracts ofcolonic
carcinoma were added to an aliquot of the
antiserum until only the CEA antigen was
recognized in extracts of colonic carcinoma
and fractions of such extracts (antiserum
anti-Ca-l-Ab, Hughes, 1975). This absorbed
antiserum was the anti-CEA serum used in
the LDA assays to be described.
(ii) Melanoma antisera were selected from
patients known to have high levels of anti-
body, as determined by 51Cr release LDA
assays against melanoma cells. Two of the
antisera, BN and MB, were from female
patients, while AB was from a male patient.
MB and AB sera were obtained 2-4 weeks
after removal of a primary melanoma, while
BN was taken from a patient with dis-
seminated melanoma.
(iii) Serum SK was from a woman at the
third trimester of her 5th pregnancy. Serum
AE was from a multiparous woman about
20 years after her last pregnancy.
51Cr-release LDA assays
These were carried out essentially as
described previously (Hersey et al., 1976).
Target cells used in the study were from the
long-term melanoma cell line MM 200,
which was obtained from Dr J. Pope of the
Queensland Institute of Medical Research.
Short-term melanoma cultures were from
melanoma tissue obtained at surgery. Meth-
ods involved in preparing the specimens
for the assay and of culture have been
described (Hersey et al., 1976). Titre of
antiserum was taken as the last dilution
giving greater than 5% 51Cr release above
the baseline release from TCs in presence
of effector cells alone.
Affinity chromatography of CEA antigen on
concanavalin-A (Con-A) sepharose 4B
1 ml of Con-A Sepharose 4B containing
8 mg of Con-A (Pharmacia Ltd) was packed
into a column constructed from a Mantoux
syringe barrel and equilibrated in Hanks'
balanced salt solution (HBSS, Common-
wealth Serum Laboratories, Melbourne). The
CEA antigen preparation (50 ,ul, 10 ,ug/ml)
was applied to the column and incubated at
room temperature for 60 min.- Any unbound
material was then washed from the column
with HBSS. A control column was prepared
by addition of a similar quantity of an
extract of intestine known to have negligible
levels of CEA by radioimmunoassay. This
was referred to as Con-A CEA- column.
Absorption of antisera
The rabbit anti-CEA serum prepared as
above was absorbed on 1/3 volume pooled
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human platelets for 30 min at 37°C and
then 1 h at 4°C to remove contaminating
species antibodies. Any immune complexes
were removed from the serum by centrifuga-
tion at 100,000 g for 90 min. The antiserum
SK collected during pregnancy was absorbed
on 1/4 volume of her husband's leucocytes
and erythrocytes to remove any contaminat-
ing HLA antibodies which may have de-
veloped during her pregnancies.
Aliquots of both the rabbit anti-CEA
serum and the pregnancy serum wN-ere
absorbed on 1/3 volume of type AB human
red blood cells. All sera Awere aliquotted and
stored at -20°C before use.
Absorptioni of antisera on( CEA
400 ,ul of the serum samples wiere applied
to the Con-A CEA column, prepared as
above, and incubated at room temperature
for 30 min. The unbound material was then
eluted with 800 ,ul of HBSS for use in the
assays. A second sample of each antiserum
was absorbed in parallel on control columnns
consisting of either Con-A alone or Con-A
CEA-.
RESULTS
Purity of the CEA preparation
When the CEA antigen preparation
was tested by Ouchterlony double diffu-
sion and immunoelectrophoresis against
the unabsorbed antiserum to perchloric-
acid extracts of colonic carcinoma, the
antiserum recognizing both CEA and
Ca-2 and the CEA antiserum, only a
single precipitin line was observed in
each case (see Fraction 2, Fig. 1). No
precipitin lines were seen when the CEA
preparation was tested by Ouchterlony
double diffusion against a polyvalent
antiserum to human serum proteins and
against 5 specific antisera (Behringwerke,
AG) to human serum proteins soluble
in 06 M perchloric acid (namely, Zn-A2-
glycoprotein, 32-glycoprotein, a2-HS-gly-
coprotein, a,-acid glycoprotein and hae-
mopexin). Stained electrophoretic pat-
terns showed that no metachromatically
staining substances were present in the
CEA preparation, but that traces of a
non-antigenic, cationic protein similar to
that previously shown to aggregate with
CEA (Hughes, 1973)
Fraction 2, Fig. 1).
were present (see
Fraction No.
-Ca
L-Ca
F'I(G. 1.--lectrophoret ic aid( imniunoelect r-
p)horetic patterns of fractionis obtained by
chromatography oni a 25 x 940 mri-i
coluimin of Sepharose 6B, usingl 0 05At
NaH2PO4 buffer, pH 4- 5, conitainling
0 -5 -m NaCI. Electrophoresis was carrie(l
out on glass slidles (25 x 76 Imm) uisinlg
1% agarose( and a (liscontiinunoLs barbital
buffer, pH 8- 6, at a coinstanit cuLrreint of
5 mA per sli(le for 25 mmil. Jrninitnio(liffti-
sioII was carriedl ouit for 48 h at 37'('.
PAS; periodic-acid Schiff staini for carbo-
hy(drate. CB, Coomassie blue stain for
proteini. Anti-Ca; inabsorbed antiserlllln
to perchloric aci(l extracts of coloniic
carciinoma. Ainti-Ca-Ab, antiserurn which
recognizes both the CEA an(' Ca-2 aniti-
genIs.
Detection of CEA-like antigen on melanomia
cells
Representative LDA assays of both
the rabbit anti-CEA serum and the
pregnancy serum SK are shown in Fig. 2
against the melanoma target cells MM 200
after absorption on either the column
of Con-A alone or the Con-A CEA column.
The rabbit antiserum to CEA had a low
level of cytotoxicity against the MM 200
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FIG. 2.-LDA activity of CEA antiserum
and pregnancy serum against MM 200
target cell both before and after absorption
on CEA. TC = % 51Cr release from target
cell alone. TC + Eff. = % 51Cr release
due to spontaneous cytotoxicity of anti-
body-dependent effector cells (s.e. of
points < 2%).
cell which extended to a titre of 1/1000.
The reason for the low level of 51Cr
release by the rabbit CEA antiserum is
not entirely clear. In 51Cr-release assays
of complement lysis of cells, the level
of 51Cr release has been related to the
antigenic density on the cell surface.
An alternative explanation which we
favour would be that only a small pro-
portion of 51Cr-labelled cells express CEA
antigen at any one time due to different
cells being in a different phase of the cell
cycle.
Immunofluorescence studies on melan-
oma cells with melanoma antisera sup-
ports such a suggestion, in that with
some antisera only 25-30% of cells were
stained at any one time (Leong, Suther-
land and Krementz, 1977). The 51Cr
release from this small proportion of
cells would then appear small in relation
to the 51Cr still present in viable intact
cells.
The low release is clearly not due to
weakness of the antiserum in that the
titre extends to beyond 1/1000.
This activity was completely removed
after the antiserum had been passed
over the Con-A CEA column. The preg-
nancy serum SK had a high level of
cytotoxicity, with a titre of 1/1000.
Absorption of this serum on the Con-A
CEA column also almost completely re-
moved the LDA activity against the
melanoma cells. Absorption of either
serum on the Con-A CEA- column or
on human AB red cells did not alter
the LDA activity to the melanoma
cells.
TABLE I.-LDA Reactivity of CEA Anti-
sera, Before and After Absorption on
CEA, to Melanoma Cells
LDA titre of CEA antisera
Target
cells
(TC)
MM 200
Chang*
ACt
LC
WC
WC
RJ
GJ
Rabbit
anti-
CEA
103
0
Absorbed
rabbit
anti-CEA
0
0
Preg-
nancy
serum
SK
102
0
102
u
102
- _ 10
-O0
Absorbed
SK
10
0
0
0
0
* Chang human liver cell line.
t Initials of donors of short-term melanoma
cultures.
-= Not tested.
In Table I the results of similar assays
of these antisera are shown against
melanoma cells from primary cultures
of melanoma tissue obtained at surgery.
One of the two primary cultures tested
with the rabbit anti-CEA serum -had
detectable CEA-like antigen 14 days
after initiation of the culture. No CEA
antigen was detectable on this cell on
the first day of the primary culture.
This did not appear to be due to any
inherent resistance to lysis of the original
cell culture in that other known melanoma
antisera appeared to show similar reac-
tivity with the cultured cells on Day 1
and on the 14thday. Two ofthe 3 primary
cultures tested with the pregnancy serum
SK showed reactivity with this serum
which was removed after absorption of
the antiserum on CEA. No reactivity
with this serum was noted against the
control Chang human liver cell line.
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Absence of LDA activity against CEA
antigens in melanoma antisera
To investigate the possibility that some
of the reactivity of melanoma antisera
may be directed against CEA antigens,
melanoma antisera from 3 patients were
absorbed on the Con-A CEA column.
The results of these studies, together
with absorption studies on antiserum
from a normal subject (AE) and the
rabbit anti-Chang serum against Chang
cells is shown in Table II. No alteration
TABLE II.-LDA Reactivity of Melanoma
Antisera Against Melanoma Cells Before
and After Absorption on CEA
Melanoma
antisera
AB
AE
BM
BN
Rabbit anti-Chang*
LDA titre to MM 200
TC's
Con A Con A CEA
absorbed absorbed
103 102
103 103
103 103
103 103
104 104
* Tested against Chang human liver cells.
of the LDA reactivity of the antisera
against the MM 200 target cells was
shown by absorption on the CEA column.
This also applied to absorption of the
rabbit anti-Chang serum, in that no
alteration of the reactivity was seen
against the control Chang cell. (Serum
from the normal subject AE was shown
in previous studies to be directed against
foetal antigens on melanoma cells [Hersey
et at., 1976].)
DISCUSSION
The above results appear to indicate
that some melanoma cells, in common
with a number of other malignancies,
express CEA or CEA-like antigens on
their surface. They also indicated that
foetal antigens shown on melanoma cells
in previous studies may, in part, be
CEA-like antigens. However, foetal anti-
gens other than CEA also appear to be
expressed on melanoma cells, in that
absorption on CEA of an antiserum
known from previous studies to react
with foetal antigens on melanoma cells,
did not remove the activity of this anti-
serum against melanoma cells (Hersey et
al., 1976).
The precise identity of the antigens
on the melanoma cell surface reacting
with the CEA antiserum has not been
defined in this study, and it is possible
that they are molecules sharing antigenic
determinants with CEA, and hence are
CEA-like antigens. To some extent, de-
scription of CEA-reactive antigens as
'CEA' or 'CEA-like' appears arbitrary,
in that CEA antigens from most sources
appear to be heterogeneous (Coligan et
al., 1973; Harvey et al., 1976). Studies to
establish further the presence of CEA
in melanoma cells by extraction pro-
cedures are in progress.
Before it can be accepted that CEA
antigen is present on some melanoma
cells, the possibility must be excluded
that the reactivity of the anti-CEA
serum may have been due to contaminat-
ing antibodies in the antiserum. This
appears unlikely, in view of the rigorous
method used in preparing the antigen
and the extensive absorption procedures
carried out on the antiserum raised
against this antigen. Antigen was pre-
pared from a metastasis of the colon
in liver by established methods (Hughes,
1973, 1975) and gave a single precipitation
line with the unabsorbed rabbit antiserum
by immunoelectrophoresis and double
diffusion in agar. These results conform
to the criteria for CEA suggested by Terry
et al. (1974). Absorption of the rabbit
antiserum to CEA and the pregnancy
antiserum, on an affinity column formed
by coupling the CEA antigen to Con-A
sepharose, removed the LDA activity
to the melanoma cells. These results
further indicated that the reactions were
specific for CEA on the cell surface.
Similar absorption procedures on rabbit
anti-Chang serum did not remove the
activity against the Chang cell, and
absorption of several melanoma antisera
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did not remove the activity against
melanoma cells which substantiated the
specificity of the absorption procedure for
CEA.
To our knowledge, there have been
no previous descriptions of LDA activity
against CEA antigens. Antibody-depen-
dent killing of tumour cells is believed
to be of possible importance in tumour
rejection (Lamon et al., 1972; O'Toole et
al., 1973; Hersey, 1973) and it would
therefore appear feasible that CEA anti-
gens may provide a target antigen for
the immune defences against tumour
growth. In the present studies however,
we have not been able to detect anti-
bodies to CEA antigens in several melan-
oma sera. Our failure to detect LDA
may reflect an absence of an IgG anti-
body response in these patients or,
alternatively, may result from absorption
of the antibody by circulating tumour
antigens. We have previously reported
that absorption of LDA by melanoma
antigens appears to be a common finding
in patieints with disseminated melanoma
(Murray, McCarthy and Hersey, 1977).
Previous studies on antibody to CEA
in the sera of tumour-bearing subjects
have also shown a low incidence of anti-
body. Gold (1967) reported that IgM
anti-CEA antibodies could be detected
in approximately 70%O of patients with
non-metastatic digestive-system cancers,
but subsequent study showed that many
of these reactions were due to anti-A
isoantibodies, and the true incidence of
antibody to CEA may be much lower
than this (Gold, Freedman and Gold,
1972). This also applied to the detection
of CEA antibodies in sera from women
during pregnancy, and the true incidence
of CEA antibodies in pregnancy may be
much lower than the figure of 7000
initially reported by Gold (1967). In
our present study, 5/15 women with
pregnancies have shown reactivity to
the melanoma target cell but we are
unable to say without more extensive
absorption studies whether this activity
is due to anti-CEA antibodies in the sera.
Quite apart from the possible biological
importance of CEA on melanoma cells,
the present findings indicate that the
application of assays for the detection
of CEA antigens in melanoma sera may
be of value in monitoring disease activity
in melanoma patients, as has been de-
scribed for a large variety of other
tumours (Neville and Laurence, 1974).
Studies to determine whether this is so
are in progress.
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